agilon health

Intangible assets: moderate. The partnership model with established physician groups, rising quality performance (75% of members in 4+ star plans for PY27; 4.2 consolidated stars), and clinical playbooks create relationship stickiness and some reputational edge, but these are replicable by larger platforms and integrated payors.

Switching costs: moderate. Deep integration into practice workflows, risk adjustment, and data pipelines raises migration frictions, yet groups can move to competing enablement platforms (or payor-owned models) over a multiyear cycle. Network effects: weak.

Local scale helps referral management but the platform does not benefit from classic cross‑side effects. Cost advantages: limited. Platform support costs run about 3% of revenue, indicating operating efficiency, but not a structural cost moat versus payor-owned or larger provider platforms.

Efficient scale: local market density helps but does not prevent entry; payors can steer attribution, limiting exclusivity. Moat erosion risks include: CMS model/rate changes (V28 fully in effect for 2026 and continuing in 2027), aggressive payor re‑contracting, and utilization spikes that compress medical margin.

Weighting stronger for switching costs and cost position yields a below‑average, fragile moat overall.